Business

Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

Telix Pharmaceuticals Limited

MELBOURNE,Australiaand INDIANAPOLIS,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today provides an update on its commercial and operational performance for th

Home Previous 2 3 4 5 6 7 8 Next Tail

10 Items Per Page (Page 5 / 119) Total 1189 Items

©copyright 2009-2020 Rubric News      Contact Us   SiteMap